Intercept Pharmaceuticals IncNASDAQ:ICPT
- LAST PRICE10.4800
- TODAY'S CHANGE (%)-0.3200 (-2.9630%)
- Bid / Lots10.0000/ 21
- Ask / Lots10.6700/ 5
- Open / Previous Close10.7300 / 10.8000
- Day Range
- 52 Week Range
- Volume1,313,031
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ICPT |
|---|---|---|
| 09:32 ET | 11230 | 10.74 |
| 09:39 ET | 2624 | 10.63 |
| 09:41 ET | 9718 | 10.58 |
| 09:43 ET | 3860 | 10.54 |
| 09:45 ET | 2865 | 10.59 |
| 09:48 ET | 1527 | 10.55 |
| 09:50 ET | 14737 | 10.47 |
| 09:52 ET | 4674 | 10.42 |
| 09:54 ET | 2329 | 10.4 |
| 09:56 ET | 3300 | 10.39 |
| 09:57 ET | 3177 | 10.35 |
| 09:59 ET | 2400 | 10.36 |
| 10:01 ET | 6552 | 10.305 |
| 10:03 ET | 25687 | 10.135 |
| 10:06 ET | 22200 | 10.18 |
| 10:08 ET | 2200 | 10.23 |
| 10:10 ET | 3874 | 10.11 |
| 10:12 ET | 5931 | 10.04 |
| 10:14 ET | 10415 | 10.01 |
| 10:15 ET | 2412 | 9.95 |
| 10:17 ET | 2200 | 9.94 |
| 10:19 ET | 2832 | 9.86 |
| 10:21 ET | 4956 | 9.9 |
| 10:24 ET | 4351 | 9.94 |
| 10:26 ET | 5185 | 9.98 |
| 10:28 ET | 1899 | 9.94 |
| 10:30 ET | 3581 | 9.995 |
| 10:32 ET | 2904 | 10 |
| 10:33 ET | 13080 | 9.95 |
| 10:35 ET | 6427 | 10 |
| 10:37 ET | 2089 | 9.94 |
| 10:39 ET | 3848 | 10.03 |
| 10:42 ET | 2121 | 9.98 |
| 10:44 ET | 17826 | 9.95 |
| 10:46 ET | 8912 | 9.94 |
| 10:48 ET | 5536 | 10.02 |
| 10:50 ET | 18673 | 10.079 |
| 10:51 ET | 12562 | 10.17 |
| 10:53 ET | 1406 | 10.17 |
| 10:55 ET | 6523 | 10.14 |
| 10:57 ET | 700 | 10.125 |
| 11:00 ET | 4704 | 10.17 |
| 11:02 ET | 600 | 10.13 |
| 11:04 ET | 3288 | 10.09 |
| 11:06 ET | 1103 | 10.08 |
| 11:08 ET | 3077 | 10.04 |
| 11:09 ET | 1700 | 10.06 |
| 11:11 ET | 1816 | 10.1 |
| 11:13 ET | 4200 | 10.095 |
| 11:15 ET | 8364 | 10.1 |
| 11:18 ET | 718 | 10.09 |
| 11:20 ET | 1467 | 10.1 |
| 11:22 ET | 500 | 10.11 |
| 11:24 ET | 1000 | 10.13 |
| 11:27 ET | 400 | 10.15 |
| 11:29 ET | 800 | 10.11 |
| 11:31 ET | 800 | 10.14 |
| 11:33 ET | 600 | 10.12 |
| 11:36 ET | 798 | 10.105 |
| 11:38 ET | 2478 | 10.15 |
| 11:40 ET | 923 | 10.18 |
| 11:42 ET | 6649 | 10.2 |
| 11:44 ET | 3125 | 10.185 |
| 11:45 ET | 1300 | 10.17 |
| 11:47 ET | 2761 | 10.195 |
| 11:49 ET | 2900 | 10.2 |
| 11:51 ET | 4600 | 10.24 |
| 11:54 ET | 1800 | 10.17 |
| 11:56 ET | 200 | 10.18 |
| 11:58 ET | 400 | 10.195 |
| 12:00 ET | 100 | 10.18 |
| 12:02 ET | 200 | 10.18 |
| 12:03 ET | 1050 | 10.2 |
| 12:05 ET | 3705 | 10.2 |
| 12:07 ET | 18844 | 10.265 |
| 12:09 ET | 1400 | 10.27 |
| 12:12 ET | 2598 | 10.33 |
| 12:14 ET | 2906 | 10.345 |
| 12:16 ET | 2400 | 10.305 |
| 12:18 ET | 6500 | 10.32 |
| 12:20 ET | 400 | 10.32 |
| 12:21 ET | 1080 | 10.28 |
| 12:23 ET | 100 | 10.295 |
| 12:25 ET | 9965 | 10.305 |
| 12:27 ET | 600 | 10.295 |
| 12:30 ET | 8144 | 10.37 |
| 12:32 ET | 900 | 10.345 |
| 12:34 ET | 1161 | 10.375 |
| 12:36 ET | 2064 | 10.43 |
| 12:39 ET | 767 | 10.45 |
| 12:41 ET | 1284 | 10.475 |
| 12:43 ET | 3401 | 10.415 |
| 12:45 ET | 3301 | 10.445 |
| 12:48 ET | 2258 | 10.47 |
| 12:50 ET | 1954 | 10.44 |
| 12:52 ET | 1336 | 10.4535 |
| 12:54 ET | 2101 | 10.45 |
| 12:57 ET | 100 | 10.45 |
| 12:59 ET | 400 | 10.45 |
| 01:01 ET | 300 | 10.45 |
| 01:03 ET | 100 | 10.44 |
| 01:06 ET | 2582 | 10.46 |
| 01:08 ET | 1100 | 10.47 |
| 01:10 ET | 1305 | 10.47 |
| 01:12 ET | 100 | 10.47 |
| 01:14 ET | 500 | 10.46 |
| 01:15 ET | 2000 | 10.45 |
| 01:19 ET | 2500 | 10.45 |
| 01:21 ET | 6080 | 10.44 |
| 01:24 ET | 1900 | 10.4 |
| 01:26 ET | 4052 | 10.4 |
| 01:28 ET | 1400 | 10.4 |
| 01:30 ET | 3213 | 10.44 |
| 01:32 ET | 2528 | 10.49 |
| 01:33 ET | 1600 | 10.495 |
| 01:35 ET | 4053 | 10.47 |
| 01:37 ET | 799 | 10.47 |
| 01:39 ET | 1612 | 10.47 |
| 01:42 ET | 8133 | 10.49 |
| 01:44 ET | 889 | 10.4825 |
| 01:46 ET | 5900 | 10.505 |
| 01:48 ET | 620 | 10.5 |
| 01:50 ET | 5821 | 10.49 |
| 01:51 ET | 465 | 10.49 |
| 01:53 ET | 400 | 10.48 |
| 01:55 ET | 5507 | 10.47 |
| 01:57 ET | 700 | 10.48 |
| 02:00 ET | 400 | 10.48 |
| 02:02 ET | 6963 | 10.47 |
| 02:04 ET | 1400 | 10.465 |
| 02:06 ET | 1200 | 10.495 |
| 02:08 ET | 600 | 10.499 |
| 02:09 ET | 2327 | 10.5 |
| 02:11 ET | 2946 | 10.52 |
| 02:13 ET | 400 | 10.495 |
| 02:15 ET | 700 | 10.51 |
| 02:18 ET | 900 | 10.505 |
| 02:20 ET | 563 | 10.5 |
| 02:22 ET | 55834 | 10.485 |
| 02:24 ET | 1800 | 10.515 |
| 02:26 ET | 9028 | 10.52 |
| 02:27 ET | 1170 | 10.51 |
| 02:29 ET | 325 | 10.49 |
| 02:31 ET | 1020 | 10.51 |
| 02:33 ET | 800 | 10.53 |
| 02:36 ET | 7389 | 10.56 |
| 02:38 ET | 1080 | 10.565 |
| 02:40 ET | 700 | 10.56 |
| 02:42 ET | 1570 | 10.53 |
| 02:44 ET | 240 | 10.53 |
| 02:45 ET | 400 | 10.52 |
| 02:47 ET | 200 | 10.52 |
| 02:49 ET | 700 | 10.52 |
| 02:51 ET | 1700 | 10.535 |
| 02:54 ET | 100 | 10.535 |
| 02:56 ET | 400 | 10.53 |
| 02:58 ET | 800 | 10.5 |
| 03:00 ET | 4620 | 10.51 |
| 03:02 ET | 900 | 10.52 |
| 03:03 ET | 1099 | 10.52 |
| 03:05 ET | 800 | 10.49 |
| 03:07 ET | 1374 | 10.505 |
| 03:09 ET | 1394 | 10.515 |
| 03:12 ET | 986 | 10.52 |
| 03:16 ET | 1600 | 10.52 |
| 03:18 ET | 654 | 10.525 |
| 03:20 ET | 974 | 10.5205 |
| 03:21 ET | 1000 | 10.525 |
| 03:23 ET | 800 | 10.525 |
| 03:25 ET | 4476 | 10.5 |
| 03:27 ET | 2176 | 10.52 |
| 03:30 ET | 600 | 10.51 |
| 03:32 ET | 1600 | 10.515 |
| 03:34 ET | 7195 | 10.5 |
| 03:36 ET | 4528 | 10.505 |
| 03:38 ET | 2163 | 10.495 |
| 03:39 ET | 2709 | 10.51 |
| 03:41 ET | 3410 | 10.505 |
| 03:43 ET | 9075 | 10.5 |
| 03:45 ET | 3973 | 10.505 |
| 03:48 ET | 14283 | 10.46 |
| 03:50 ET | 8545 | 10.5 |
| 03:52 ET | 9401 | 10.505 |
| 03:54 ET | 17388 | 10.495 |
| 03:56 ET | 17285 | 10.45 |
| 03:57 ET | 79767 | 10.47 |
| 03:59 ET | 138974 | 10.48 |
Sep 5, 2023
Intercept Pharmaceuticals to Conduct Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences, from 8:30AM ET on Tuesday Sep 05, 2023 by Dow Jones
8:30AM ET on Tuesday Sep 05, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Intercept Pharmaceuticals Inc | 437.9M | -2.4x | --- |
Iteos Therapeutics Inc | 408.6M | -13.9x | --- |
CareDx Inc | 414.9M | -4.9x | --- |
Akebia Therapeutics Inc | 222.2M | -2.2x | --- |
Vanda Pharmaceuticals Inc | 259.4M | 17.5x | --- |
Coherus BioSciences Inc | 474.5M | -1.3x | --- |
Company Information
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company that is focused on the development and commercialization of therapeutics to treat progressive non-viral liver diseases with unmet medical need utilizing its bile acid chemistry. Its product candidates include Ocaliva (obeticholic (OCA)) for liver fibrosis due to nonalcoholic steatohepatitis (NASH), OCA and Bezafibrate, and Other Product Candidates. The Company’s marketed product, Ocaliva, is a farnesoid X receptor (FXR) agonist for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA. The Company is evaluating tolerability of OCA in combination with bezafibrate in patients with PBC in a Phase II study outside of the United States. Its other compounds are in early stages of research and development pipeline including INT-787 compound, an FXR agonist is in a Phase IIa clinical trial.
Contact Information
- Headquarters
- 305 Madison AvenueMORRISTOWN, NJ, United States 07960
- Phone
- 646-747-1000
- Fax
- 646-747-1001
Executives
- Independent Chairman of the Board
- Paolo Fundaro
- President, Chief Executive Officer, Director
- Jerome Durso
- Chief Financial Officer
- Andrew Saik
- President of Research and Development; Chief Medical Officer
- M. Michelle Berrey
- Chief Human Resource Officer
- David Ford
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $437.9M |
|---|---|
Revenue (TTM) | $306.5M |
Shares Outstanding | 41.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.21 |
EPS | $-4.35 |
Book Value | $2.24 |
P/E Ratio | -2.4x |
Price/Sales (TTM) | 1.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -51.77% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
